PNC FINANCIAL SERVICES GROUP, INC. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,537
+31.6%
338
+103.6%
0.00%
Q2 2023$1,168
+15.2%
1660.0%0.00%
Q1 2023$1,014
+231.4%
166
+245.8%
0.00%
Q4 2022$30648
-50.0%
0.00%
Q3 2022$0
-100.0%
96
-52.9%
0.00%
Q2 2022$1,000
-75.0%
204
-19.7%
0.00%
Q1 2022$4,000
-90.5%
254
-88.7%
0.00%
Q4 2021$42,000
-63.8%
2,257
-51.8%
0.00%
Q3 2021$116,000
+544.4%
4,681
+579.4%
0.00%
Q2 2021$18,000
+50.0%
689
+80.4%
0.00%
Q1 2021$12,000
-25.0%
382
+13.0%
0.00%
Q4 2020$16,000
+60.0%
338
+4.6%
0.00%
Q3 2020$10,000
+11.1%
323
-9.8%
0.00%
Q2 2020$9,000
+200.0%
358
+219.6%
0.00%
Q1 2020$3,0000.0%112
+12.0%
0.00%
Q4 2019$3,000
+50.0%
1000.0%0.00%
Q3 2019$2,0000.0%1000.0%0.00%
Q2 2019$2,000
+100.0%
1000.0%0.00%
Q1 2019$1,0000.0%1000.0%0.00%
Q4 2018$1,000
-92.3%
100
-90.9%
0.00%
Q3 2018$13,000
+8.3%
1,100
+10.0%
0.00%
Q2 2018$12,000
-25.0%
1,0000.0%0.00%
Q1 2018$16,000
+100.0%
1,0000.0%0.00%
Q4 2017$8,0000.0%1,0000.0%0.00%
Q3 2017$8,0000.0%1,000
-3.6%
0.00%
Q2 2017$8,0001,0370.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders